Colorimetric and fluorometric reverse transcription loop-mediated isothermal amplification (RT-LAMP) assay for diagnosis of SARS-CoV-2.
COVID-19
Colorimetric
Coronavirus
Diagnosis
Fluorometric
RT-LAMP
SARS-CoV-2
Journal
Functional & integrative genomics
ISSN: 1438-7948
Titre abrégé: Funct Integr Genomics
Pays: Germany
ID NLM: 100939343
Informations de publication
Date de publication:
Dec 2022
Dec 2022
Historique:
received:
08
03
2022
accepted:
04
09
2022
revised:
19
07
2022
pubmed:
12
9
2022
medline:
30
11
2022
entrez:
11
9
2022
Statut:
ppublish
Résumé
The coronavirus disease 2019 (COVID-19) caused by the severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2) has caused millions of infections and deaths worldwide since it infected humans almost 3 years ago. Improvements of current assays and the development of new rapid tests or to diagnose SARS-CoV-2 are urgent. Reverse transcription loop-mediated isothermal amplification (RT-LAMP) is a rapid and propitious assay, allowing to detect both colorimetric and/or fluorometric nucleic acid amplifications. This study describes the analytical and clinical evaluation of RT-LAMP assay for detection of SARS-CoV-2, by designing LAMP primers targeting N (nucleocapsid phosphoprotein), RdRp (polyprotein), S (surface glycoprotein), and E (envelope protein) genes. The assay's performance was compared with the gold standard RT-PCR, yielding 94.6% sensitivity and 92.9% specificity. Among the tested primer sets, the ones for S and N genes had the highest analytical sensitivity, showing results in about 20 min. The colorimetric and fluorometric comparisons revealed that the latter is faster than the former. The limit of detection (LoD) of RT-LAMP reaction in both assays is 50 copies/µl of the reaction mixture. However, the simple eye-observation advantage of the colorimetric assay (with a color change from yellow to red) serves a promising on-site point-of-care testing method anywhere, including, for instance, laboratory and in-house applications.
Identifiants
pubmed: 36089609
doi: 10.1007/s10142-022-00900-5
pii: 10.1007/s10142-022-00900-5
pmc: PMC9464610
doi:
Substances chimiques
RNA, Viral
0
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
1391-1401Subventions
Organisme : University of Dammam
ID : COVID19-2020-026-IRMC
Organisme : University of Dammam
ID : 2020-IRMC-S-3
Informations de copyright
© 2022. The Author(s), under exclusive licence to Springer-Verlag GmbH Germany, part of Springer Nature.
Références
Sci Rep. 2021 Apr 27;11(1):9026
pubmed: 33907239
PLoS One. 2015 Dec 07;10(12):e0142075
pubmed: 26641662
J Appl Microbiol. 2018 Mar;124(3):626-643
pubmed: 29165905
JCI Insight. 2020 Oct 2;5(19):
pubmed: 32870820
Sci Rep. 2022 Feb 18;12(1):2853
pubmed: 35181721
J Virol Methods. 2015 Apr;215-216:13-6
pubmed: 25682750
Nat Biotechnol. 2020 May;38(5):515-518
pubmed: 32203294
J Virol Methods. 2018 Oct;260:45-48
pubmed: 29936095
Anal Chem. 2020 Aug 18;92(16):11305-11309
pubmed: 32605363
Brief Bioinform. 2019 Jul 19;20(4):1160-1166
pubmed: 28968734
Biosens Bioelectron. 2020 Oct 1;165:112454
pubmed: 32729549
Life Sci. 2021 May 15;273:119117
pubmed: 33508293
J Biochem Biophys Methods. 2004 May 31;59(2):145-57
pubmed: 15163526
Med Hypotheses. 2020 Aug;141:109786
pubmed: 32361529
Biotechnol Prog. 2021 Jan;37(1):e3078
pubmed: 32902193
Mol Med. 2021 Mar 26;27(1):30
pubmed: 33771097
Sci Transl Med. 2020 Aug 12;12(556):
pubmed: 32719001
Nat Commun. 2021 Feb 5;12(1):802
pubmed: 33547323
Clin Infect Dis. 2020 Jul 28;71(15):793-798
pubmed: 32221523
PLoS One. 2021 Apr 29;16(4):e0250942
pubmed: 33914804
Int J Mol Sci. 2020 Jul 29;21(15):
pubmed: 32751106
Nat Biotechnol. 2020 Jul;38(7):870-874
pubmed: 32300245
Chem Eng Sci. 2022 Apr 6;251:117430
pubmed: 35043022
Microb Biotechnol. 2020 Jul;13(4):950-961
pubmed: 32333644
Clin Chem. 2021 Jan 30;67(2):415-424
pubmed: 33098427
ACS Nano. 2020 Apr 28;14(4):5135-5142
pubmed: 32293168
Int J Infect Dis. 2022 Mar;116:133-137
pubmed: 34958929
Vaccines (Basel). 2021 Jul 09;9(7):
pubmed: 34358186
Cells. 2022 Mar 31;11(7):
pubmed: 35406746
BMC Infect Dis. 2021 May 26;21(1):478
pubmed: 34039287
J Appl Microbiol. 2019 May;126(5):1332-1339
pubmed: 29851222
J Med Virol. 2020 Sep;92(9):1518-1524
pubmed: 32104917
Bioinformatics. 2009 May 1;25(9):1189-91
pubmed: 19151095
Clin Microbiol Infect. 2020 Jun;26(6):773-779
pubmed: 32276116
Sci Rep. 2021 Aug 12;11(1):16430
pubmed: 34385527
J Virol Methods. 2018 Aug;258:41-48
pubmed: 29763640
Analyst. 2021 Jan 21;146(2):471-477
pubmed: 33165486
J Virol Methods. 2017 May;243:105-108
pubmed: 28109842